Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic profile and clinical features of MSI-H and TMB-high pancreatic cancers: real-world data from C-CAT database
Tomoki Sakakida, Takeshi Ishikawa, Toshifumi Doi, et al.
Journal of Gastroenterology (2023) Vol. 59, Iss. 2, pp. 145-156
Closed Access | Times Cited: 12

Showing 12 citing articles:

Efficacy of pembrolizumab in microsatellite-stable, tumor mutational burden-high metastatic colorectal cancer: genomic signatures and clinical outcomes
Toshihiro Yamaguchi, Kenji Tsuchihashi, Sayaka Ueno, et al.
ESMO Open (2025) Vol. 10, Iss. 1, pp. 104108-104108
Open Access | Times Cited: 2
Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort
Norihisa Ichimura, Yusuke Urata, Takeru KOBAYASHI, et al.
Oral Oncology (2024) Vol. 152, pp. 106807-106807
Open Access | Times Cited: 6
Current status of cancer genome medicine for pancreatic ductal adenocarcinoma
Toshifumi Doi, Takeshi Ishikawa, Michihisa Moriguchi, et al.
Japanese Journal of Clinical Oncology (2025)
Closed Access
Threading the Needle: Navigating Novel Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
Tarık Demir, Carolyn Moloney, Devalingam Mahalingam
Cancers (2025) Vol. 17, Iss. 5, pp. 715-715
Open Access
Case Report: Medullary carcinoma of the pancreas with MLH1 promoter hypermethylation, induced deficient mismatch repair, successfully treated with an immune checkpoint inhibitor
Koushiro Ohtsubo, Shigeki Sato, Hiroyuki Sakaguchi, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Inflammation, Immunosuppression, and Immunotherapy in Pancreatic Cancer—Where Are We Now?
Marta Fudalej, Katherine Krupa, Anna Badowska-Kozakiewicz, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1484-1484
Open Access
Factors associated with actionable gene aberrations in pancreatic cancer based on the C-CAT database
Go Endo, Kazunaga Ishigaki, Yousuke Nakai, et al.
Journal of Gastroenterology (2025)
Open Access
Subtype-Specific Patterns of Tumor Purity and Mutation Load Suggest Treatment Implications
Daniel Schneider, Ethan Brown, Jacob Gluski, et al.
American Journal of Clinical Oncology (2025)
Closed Access
Exploring CISD1 as a multifaceted biomarker in cancer: Implications for diagnosis, prognosis, and immunotherapeutic response
Caiyue Li, Zhipin Liang, Gabrielle Vontz, et al.
Genes & Diseases (2025), pp. 101677-101677
Open Access
Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database
Kazunaga Ishigaki, Yurie Tokito, Naminatsu Takahara, et al.
Journal of Gastroenterology (2024)
Open Access | Times Cited: 2
Long-term survival after systemic chemotherapy, chemoradiotherapy, and maintenance therapy for an older adult patient with recurrent pancreatic acinar cell carcinoma
Makiko Urabe, Kenji Ikezawa, Kazuhiro Kozumi, et al.
Clinical Journal of Gastroenterology (2024) Vol. 17, Iss. 4, pp. 771-775
Closed Access | Times Cited: 1
Real‐world genome profiling in Japanese patients with pancreatic ductal adenocarcinoma focusing on HRD implications
Toshifumi Doi, Takeshi Ishikawa, Tomoki Sakakida, et al.
Cancer Science (2024)
Open Access | Times Cited: 1
Quantification of PD-L1 expression and tumor mutational burden in biologically distinct advanced pancreatic cancers responding to pembrolizumab: case reports
Kevin Y. Li, Andrew M. Lowy, Paul T. Fanta
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Mutational landscape of Japanese patients with oral squamous cell carcinoma from comprehensive genomic profiling tests
Norihisa Ichimura, Yusuke Urata, Takeru KOBAYASHI, et al.
Oral Oncology (2024) Vol. 159, pp. 107079-107079
Open Access
C-CAT's triumph in gastroenterology: the wisdom of cats is infinitely superior
Masaru Enomoto, Naoshi Odagiri, Koji Rinka, et al.
Journal of Gastroenterology (2023) Vol. 59, Iss. 2, pp. 157-158
Closed Access
Page 1

Scroll to top